Our publications

More than 13,000 men and women in Quebec (about 36 per day) die each year from tobacco-related diseases. Although the prevalence of tobacco use has declined in the past decade, there are still 1.6 million smokers in the province who inhale more than 4,000 chemical products each day, at least 50 of which are carcinogenic.

More than 13,000 men and women in Quebec (about 36 per day) die each year from tobacco-related diseases. Although the prevalence of tobacco use has declined in the past decade, there are still 1.6 million smokers in the province who inhale more than 4,000 chemical products each day, at least 50 of which are carcinogenic.

More than 13,000 men and women in Quebec (about 36 per day) die each year from tobacco-related diseases. Although the prevalence of tobacco use has declined in the past decade, there are still 1.6 million smokers in the province who inhale more than 4,000 chemical products each day, at least 50 of which are carcinogenic.

More than 13,000 men and women in Quebec (about 36 per day) die each year from tobacco-related diseases. Although the prevalence of tobacco use has declined in the past decade, there are still 1.6 million smokers in the province who inhale more than 4,000 chemical products each day, at least 50 of which are carcinogenic.

More than 13,000 men and women in Quebec (about 36 per day) die each year from tobacco-related diseases. Although the prevalence of tobacco use has declined in the past decade, there are still 1.6 million smokers in the province who inhale more than 4,000 chemical products each day, at least 50 of which are carcinogenic.

The Québec WHO Collaborating Centre (CC) for Safety Promotion and Injury Prevention, established in 1995, comprises institutions in the Québec public health network, i.e. four regional public health branches (Montréal, Montérégie, Capitale-Nationale and Bas-Saint-Laurent), the Direction générale de la santé publique in the ministère de la Santé et des Services sociaux, and the Institut national de santé publique du Québec.

SurvUDI is a network for the epidemiological surveillance of human immunodeficiency virus infection among injection drug users. The network was established in 1995, and covers eight districts in Québec, and Ottawa. Individuals who participate report injecting drugs during the six preceding months and are recruited mainly through centres that provide access to sterile injection equipment. A two-part study on hepatitis C (HCV) was appended to the SurvUDI network.

As of June 30, 2004, 14,773 questionnaires had been administered to 8,964 individuals (Table 1).

Three-quarters of participants are men (6,542/8,964) with an average age of 33. The average age of female participants is 28 (Table 1).

Educational levels are low, with only one in four (269/1,105) participants having completed high school (Table 3; 2003-04 data).

A series of field trials were completed to inter-compare ground deposition from ground and aerial sprays of Fyfanon® ULV adulticide and to compare these results with others predicted by AGDISP. A ground cold-aerosol generator (Clarke GRIZZLY) was used in wind conditions ranging from 3.6 to 12.4 kph. Deposit samples (fiberglass filters) were taken at 10 m intervals to 500 m downwind. Collocated at alternate sites, the spray cloud at 1.4 m height was characterized using rotating 3 mm rods to…

Since 2000, cancer has been the main cause of death in Quebec (Institut de la statistique du Québec, 2003). However, the standardized death rate due to cancer, like most other causes of death, has been declining steadily since the early 1990s (ministère de la Santé et des Services sociaux, 2003; ministère de la Santé et des Services sociaux, 2004), while life expectancy at birth of the Quebec population has increased in recent decades. With the number of seniors growing steadily and the risk…